Related Experiment Video
Updated: Jul 15, 2026
06:23
Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence
Published on: January 17, 2025
Phenomics and lamins: from disease to therapy
Robert A Hegele1, Junko Oshima
1Schulich School of Medicine and Dentistry, University of Western Ontario and Vascular Biology Research Group, Robarts Research Institute, London, Ontario, Canada N6A 5K8. hegele@robarts.ca
Experimental Cell Research
|May 1, 2007
Summary
Phenomics links genetic mutations to physical traits, aiding disease understanding. Studying laminopathies reveals genotype-phenotype links, guiding treatments for rare and common metabolic disorders.
Area of Science:
- Genetics and genomics
- Systems biology
- Medical research
Background:
- Phenomics aims to correlate phenotypes with genotypes for complex disease definition.
- Monogenic disorders like laminopathies offer models for studying phenotype-genotype associations.
- Understanding these links can generate hypotheses and suggest therapeutic strategies.
Purpose of the Study:
- To explore phenotype-genotype associations in laminopathies.
- To investigate how LMNA mutations influence clinical features and organ involvement.
- To identify potential intervention strategies for laminopathies and related metabolic disorders.
Main Methods:
- Clinical evaluation of familial partial lipodystrophy kindreds with mutant LMNA.
- Non-invasive imaging to differentiate LMNA-related lipodystrophy.
- Hierarchical cluster analysis of organ involvement and LMNA mutation position.
- Review of emerging treatment modalities like farnesyl transferase inhibition and gene therapy.
Main Results:
- Phenotypic differences observed between LMNA-related and non-LMNA-related partial lipodystrophy.
- Systematic relationships identified between organ involvement in laminopathies and LMNA mutation site.
- Potential for staged pharmaceutical interventions to prevent cardiovascular complications.
Conclusions:
- Phenotype-genotype correlations in laminopathies provide insights into disease mechanisms.
- Understanding genotype-phenotype variability is crucial for explaining divergent clinical presentations.
- Novel therapies targeting early pathogenic steps offer hope for laminopathy patients.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...